The concept that dysregulated IL-6 gene expression can initiate polyclonal plasmacytosis and subsequently lead to the development of a malignant monoclonal plasmacytoma is well supported by the available data [63,64,65]. The gene discussed is IL6; the disease is plasmacytoma.